2010
DOI: 10.1016/j.jpedsurg.2010.02.116
|View full text |Cite
|
Sign up to set email alerts
|

Chest wall repair with engineered fetal bone grafts: an efficacy analysis in an autologous leporine model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
28
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 33 publications
(30 citation statements)
references
References 25 publications
(30 reference statements)
2
28
0
Order By: Relevance
“…These two markers were not proposed by International Society for Cellular Therapy (ISCT; Dominici et al, 2006), however they are often used to detect MSC populations. There are many other studies of AF-MSCs, which found theses markers to be expressed in human (In't Anker et al, 2003;Tsai et al, 2004;De Coppi et al, 2007), rabbit (Steigman et al, 2009;Klein et al, 2010;DeKoninck et al, 2013;Fei et al, 2013;Kováč et al, 2016) and other species (Park et al, 2011;Chen et al, 2011;Nadri and Soleimani, 2007;Iacono et al, 2012;Choi et al, 2013). Investigators therefore use CD29 and CD44 together with some of molecular markers proposed for human MSCs by ISCT.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…These two markers were not proposed by International Society for Cellular Therapy (ISCT; Dominici et al, 2006), however they are often used to detect MSC populations. There are many other studies of AF-MSCs, which found theses markers to be expressed in human (In't Anker et al, 2003;Tsai et al, 2004;De Coppi et al, 2007), rabbit (Steigman et al, 2009;Klein et al, 2010;DeKoninck et al, 2013;Fei et al, 2013;Kováč et al, 2016) and other species (Park et al, 2011;Chen et al, 2011;Nadri and Soleimani, 2007;Iacono et al, 2012;Choi et al, 2013). Investigators therefore use CD29 and CD44 together with some of molecular markers proposed for human MSCs by ISCT.…”
Section: Resultsmentioning
confidence: 99%
“…Although rAF-MSCs were previously defined by a few studies (Steigman et al, 2009;Klein et al, 2010;DeKoninck et al, 2013;Fei et al, 2013), some of the MSC markers, like CD73, CD105 and 166 were not previously screened in rAF-MSCs. A negative expression of surface markers detected by flow cytometry could also be possibly attributed to antibodies specificity.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations